/PRNewswire/ The "Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com s offering. The.
/PRNewswire/ Rarecells, Inc., an innovative Liquid Biopsy company developing non-invasive tests for early cancer diagnosis, announced today the closing of a.